PURPOSE: Proliferation activity has long been known to be one of the strongest prognostic factors in many different cancers. Nevertheless, microscopic evaluation of mitotic figures remains time-consuming and, furthermore, is relatively subjective. As the expression of cytoskeleton-associated protein 2 (CKAP2) is closely related to the mitotic phase, CKAP2 was evaluated as a surrogate mitotic figure (MF) marker. METHODS: A monoclonal antibody specific to human CKAP2 was produced, and immunohistochemistry was performed on normal tissue array sections and 30 breast cancer tissues. RESULTS: The expression of CKAP2 in the normal human tissues was limited to well-known cell proliferation zones. Strong, readily visible, condensed chromatin staining of CKAP2 was observed specifically in mitotic cells, and the number of these cells was tightly correlated with the MF count in breast cancer tissues (P < 0.001, ρ = 0.743), suggesting its usefulness as a surrogate marker for MF counting. CONCLUSION: Immunohistochemical staining with CKAP2 monoclonal antibody can be considered to be a new, effective approach to the assessment of proliferation activity in cancer tissues.
PURPOSE: Proliferation activity has long been known to be one of the strongest prognostic factors in many different cancers. Nevertheless, microscopic evaluation of mitotic figures remains time-consuming and, furthermore, is relatively subjective. As the expression of cytoskeleton-associated protein 2 (CKAP2) is closely related to the mitotic phase, CKAP2 was evaluated as a surrogate mitotic figure (MF) marker. METHODS: A monoclonal antibody specific to humanCKAP2 was produced, and immunohistochemistry was performed on normal tissue array sections and 30 breast cancer tissues. RESULTS: The expression of CKAP2 in the normal human tissues was limited to well-known cell proliferation zones. Strong, readily visible, condensed chromatin staining of CKAP2 was observed specifically in mitotic cells, and the number of these cells was tightly correlated with the MF count in breast cancer tissues (P < 0.001, ρ = 0.743), suggesting its usefulness as a surrogate marker for MF counting. CONCLUSION: Immunohistochemical staining with CKAP2 monoclonal antibody can be considered to be a new, effective approach to the assessment of proliferation activity in cancer tissues.
Authors: P J van Diest; J P Baak; P Matze-Cok; E C Wisse-Brekelmans; C M van Galen; P H Kurver; S M Bellot; J Fijnheer; L H van Gorp; W S Kwee Journal: Hum Pathol Date: 1992-06 Impact factor: 3.466
Authors: L Maouche-Chrétien; N Deleu; C Badoual; P Fraissignes; R Berger; P Gaulard; P H Roméo; K Leroy-Viard Journal: Oncogene Date: 1998-09-10 Impact factor: 9.867
Authors: Yijiang Shi; Tony Reiman; Weiqun Li; Christopher A Maxwell; Subrata Sen; Linda Pilarski; Tracy R Daniels; Manuel L Penichet; Rick Feldman; Alan Lichtenstein Journal: Blood Date: 2007-01-09 Impact factor: 22.113
Authors: Phyllis A Gimotty; Patricia Van Belle; David E Elder; Todd Murry; Kathleen T Montone; Xiaowei Xu; Susan Hotz; Shane Raines; Michael E Ming; Peter Wahl; Dupont Guerry Journal: J Clin Oncol Date: 2005-11-01 Impact factor: 44.544
Authors: D Amadori; O Nanni; M Marangolo; P Pacini; A Ravaioli; A Rossi; A Gambi; G Catalano; D Perroni; E Scarpi; D C Giunchi; A Tienghi; A Becciolini; A Volpi Journal: J Clin Oncol Date: 2000-09 Impact factor: 44.544
Authors: Jan P A Baak; Einar Gudlaugsson; Ivar Skaland; Lydia Hui Ru Guo; Jan Klos; Tone Hoel Lende; Håvard Søiland; Emiel A M Janssen; Axel Zur Hausen Journal: Breast Cancer Res Treat Date: 2008-07-30 Impact factor: 4.872
Authors: Lyndsay Harris; Herbert Fritsche; Robert Mennel; Larry Norton; Peter Ravdin; Sheila Taube; Mark R Somerfield; Daniel F Hayes; Robert C Bast Journal: J Clin Oncol Date: 2007-10-22 Impact factor: 44.544
Authors: Peter C Fong; David S Boss; Timothy A Yap; Andrew Tutt; Peijun Wu; Marja Mergui-Roelvink; Peter Mortimer; Helen Swaisland; Alan Lau; Mark J O'Connor; Alan Ashworth; James Carmichael; Stan B Kaye; Jan H M Schellens; Johann S de Bono Journal: N Engl J Med Date: 2009-06-24 Impact factor: 91.245